CENTURION THERAPEUTICS
Live / Allowed — First extension granted (statement of use) (as of 20 Apr 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 Sept 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98764463
- Mark type
- Word mark
- Filed
- 23 Sept 2024
- Published for opposition
- 09 Sept 2025
- Attorney of record
- Neil I Jacobs
Goods and services
- Class 005 — Pharmaceuticals: human allograft tissue, namely, human allograft tissue for topical use comprised of tissue from placental membranes; human allograft tissue derived from placental and dermal tissue; wound dressings; wound dressings derived from placental and dermal tissue
Owner
- Centurion Therapeutics. Inc., Marshfield, MA, US
- Centurion Therapeutics. Inc., Marshfield, MA, US
Prosecution history
- 21 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Apr 2026 — SOU EXTENSION 1 GRANTED
- 20 Apr 2026 — SOU EXTENSION 1 FILED
- 20 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 04 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Sept 2025 — PUBLISHED FOR OPPOSITION
- 03 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Jul 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Apr 2025 — NON-FINAL ACTION E-MAILED
- 15 Apr 2025 — NON-FINAL ACTION WRITTEN